Perampanel add‐on vs placebo
50% or greater reduction in seizure frequency · people (aged 12 years and over) with drug‐resistant focal epilepsy
Perampanel add‐on leads to higher ≥ 50% reduction in seizure frequency compared with placebo (high certainty).
1 finding from 1 review
- RR 1.67 [1.43, 1.95]7 studies · 2524 participantsHigh